AAAAAA

   
Results: 1-11 |
Results: 11
NIMODIPINE MONOTHERAPY AND CARBAMAZEPINE AUGMENTATION IN PATIENTS WITH REFRACTORY RECURRENT AFFECTIVE-ILLNESS
Authors: PAZZAGLIA PJ POST RM KETTER TA CALLAHAN AM MARANGELL LB FRYE MA GEORGE MS KIMBRELL TA LEVERICH GS CORALOCATELLI G LUCKENBAUGH D
Citation: Pj. Pazzaglia et al., NIMODIPINE MONOTHERAPY AND CARBAMAZEPINE AUGMENTATION IN PATIENTS WITH REFRACTORY RECURRENT AFFECTIVE-ILLNESS, Journal of clinical psychopharmacology, 18(5), 1998, pp. 404-413
CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS
Authors: FRYE MA KETTER TA ALTSHULER LL DENICOFF K DUNN RT KIMBRELL TA CORALOCATELLI G POST RM
Citation: Ma. Frye et al., CLOZAPINE IN BIPOLAR DISORDER - TREATMENT IMPLICATIONS FOR OTHER ATYPICAL ANTIPSYCHOTICS, Journal of affective disorders, 48(2-3), 1998, pp. 91-104
GABAPENTIN AUGMENTATION FOR FLUOXETINE-TREATED PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER
Authors: CORALOCATELLI G GREENBERG BD MARTIN J MURPHY DL
Citation: G. Coralocatelli et al., GABAPENTIN AUGMENTATION FOR FLUOXETINE-TREATED PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER, The Journal of clinical psychiatry, 59(9), 1998, pp. 480-481
REBOUND PSYCHIATRIC AND PHYSICAL SYMPTOMS AFTER GABAPENTIN DISCONTINUATION
Authors: CORALOCATELLI G GREENBERG BD MARTIN JD MURPHY DL
Citation: G. Coralocatelli et al., REBOUND PSYCHIATRIC AND PHYSICAL SYMPTOMS AFTER GABAPENTIN DISCONTINUATION, The Journal of clinical psychiatry, 59(3), 1998, pp. 131-131
VALPROATE MONOTHERAPY IN AN SRI-INTOLERANT OCD PATIENT
Authors: CORALOCATELLI G GREENBERG BD MARTIN JD MURPHY DL
Citation: G. Coralocatelli et al., VALPROATE MONOTHERAPY IN AN SRI-INTOLERANT OCD PATIENT, The Journal of clinical psychiatry, 59(2), 1998, pp. 82-82
INTRACORTICAL INHIBITION IN OBSESSIVE-COMPULSIVE DISORDER
Authors: GREENBERG BD ZIEMANN U HARMON AM CORALOCATELLI G MURPHY DL WASSERMANN EM
Citation: Bd. Greenberg et al., INTRACORTICAL INHIBITION IN OBSESSIVE-COMPULSIVE DISORDER, Neurology, 50(4), 1998, pp. 56002-56002
CORTICAL EXCITABILITY AND AUGMENTATION STRATEGIES IN OCD
Authors: CORALOCATELLI G GREENBERG BD HARMON A MARTIN J ZIEMANN U WASSERMAN E LEONG YM MURPHY DL
Citation: G. Coralocatelli et al., CORTICAL EXCITABILITY AND AUGMENTATION STRATEGIES IN OCD, Biological psychiatry, 43, 1998, pp. 258-258
CSF NEUROPEPTIDE-Y CORRELATES WITH ANXIETY IN PATIENTS WITH AFFECTIVE-DISORDERS
Authors: OSUCH EA FRYE MA LITTLE JT KIMBRELL TA HUGGINS T DUNN R SPEER A CORALOCATELLI G VANDERHAM L POST RM MATHE AA
Citation: Ea. Osuch et al., CSF NEUROPEPTIDE-Y CORRELATES WITH ANXIETY IN PATIENTS WITH AFFECTIVE-DISORDERS, Biological psychiatry, 43, 1998, pp. 339-339
CSF NEUROPEPTIDE DYSREGULATION IN PATIENTS WITH AFFECTIVE-DISORDER
Authors: FRYE MA MATHE AA GARY KA GEORGE MS CORALOCATELLI G HUGGINS T PAZZAGLIA PJ CALLAHAN AM DAVIS C MARANGELL L RUBINOW D WINOKUR A POST RM
Citation: Ma. Frye et al., CSF NEUROPEPTIDE DYSREGULATION IN PATIENTS WITH AFFECTIVE-DISORDER, Biological psychiatry, 39(7), 1996, pp. 327-327
CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITOR RO 40-7592 PROLONGS DURATION OF ACTION OF LEVODOPA CARBIDOPA IN PARKINSONIAN-PATIENTS
Authors: ROBERTS JW CORALOCATELLI G BRAVI D METMAN LV MOURADIAN MM CHASE TN
Citation: Jw. Roberts et al., CATECHOL-O-METHYLTRANSFERASE (COMT) INHIBITOR RO 40-7592 PROLONGS DURATION OF ACTION OF LEVODOPA CARBIDOPA IN PARKINSONIAN-PATIENTS, Neurology, 43(4), 1993, pp. 332-332
CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE PROLONGS LEVODOPA CARBIDOPA ACTION IN PARKINSONIAN-PATIENTS
Authors: ROBERTS JW CORALOCATELLI G BRAVI D AMANTEA MA MOURADIAN MM CHASE TN
Citation: Jw. Roberts et al., CATECHOL-O-METHYLTRANSFERASE INHIBITOR TOLCAPONE PROLONGS LEVODOPA CARBIDOPA ACTION IN PARKINSONIAN-PATIENTS, Neurology, 43(12), 1993, pp. 2685-2688
Risultati: 1-11 |